Abstract:Introduction Monoclonal antibodies (mAbs) play a pivotal role in disease diagnosis as well as immunotherapy interventions. Traditional monoclonal antibody generation relies on animal immunization procedures predominantly involving mice; however, recent advances in in-vitro expression methodologies have enabled large-scale production suitable for both industrial applications as well as scientific investigations. Methods In this study, two mAbs against H7 subtype avian influenza viruses (AIV) were sequenced and analyzed, and the DNA sequences encoding heavy chain (HC) and light chain (LC) were obtained and cloned into pCHO-1.0 expression vector. Then, the HC and LC expression plasmids were transfected into CHO-S cells to establish stable cell lines expressing these mAbs using a two-phase selection scheme with different concentrations of methotrexate and puromycin. Recombinant antibodies were purified from the cell culture medium, and their potential applications were evaluated using hemagglutination inhibition (HI), western blotting (WB), confocal microscopy, and enzyme-linked immunosorbent assay (ELISA). Results The results indicated that the obtained recombinant antibodies exhibited biological activity similar to that of the parent antibodies derived from ascites and could be used as a replacement for animal-derived mAbs. A kinetic analysis of the two antibodies to the AIV HA protein, conducted using surface plasmon resonance (SPR), showed concordance between the recombinant and parental antibodies. Discussion The data presented in this study suggest that the described antibody production protocol could avoid the use of experimental animals and better conform to animal welfare regulations, and provides a basis for further research and development of mAbs-based diagnostic products.

Preparation of Novel Anti-Ski Monoclonal Antibodies.

Generation and Characterization of Four Novel Monoclonal Antibodies Against Human Programmed Death-1 Molecule.

[Preparation and Characterization of Monoclonal Antibody Against Human Telomeric Repeat Binding Factor 1].

Development of a rabbit monoclonal antibody group against Smads and immunocytochemical study of human and mouse embryonic stem cells.

Production and Characterization of a Monoclonal Antibody Against GRAM Domain-Containing Protein 1A

Generation and Characterisation of Rabbit Monoclonal Antibodies Against the Native Cell Surface Antigens of Embryonic Stem Cells.

A Novel Polyclonal Antibody Against Human Cytomegalovirus: General Characteristics and Potential Application in Diagnosis

Isolation of human cDNA clones of ski and the ski-related gene, sno

Identification and primary application of hybridomas cell secreting monoclonal antibodies against mink (Neovison vison) interferon-gamma

Preparation of Antispermidine/Spermine-N1-Acetyltransferase Monoclonal Antibodies.

Preparation of a new monoclonal antibody against subgroup A of avian leukosis virus and identifying its antigenic epitope

Preparation and Characterization of Monoclonal Antibodies Against VSTM1.

Preparation and Identification of the Monoclonal Antibody Against Human Bone Sialoprotein

Ski: Double roles in cancers

Preparation and Characterization of a Monoclonal Antibody Against Human B Lymphocyte Stimulator

Expression and characterization of recombinant antibodies against H7 subtype avian influenza virus and their diagnostic potential

Preparation and Identification of the Rabbit Anti-human Immune-related Gene Guanosine Triphosphate Polyclonal Antibody

Preparation and Characterization of Monoclonal Antibody Against Human Angiopoietin-Like Protein 2

Preparation of anti-human esophageal cancer invasion and metastasis functional monoclonal antibody

Preparation and Identification of Monoclonal Antibodies Against M Protein of Avian Infectious Bronchitis Virus

Production And Characterization Of Monoclonal Antibodies To (Poly100)S1 Protein Of Avian Infectious Bronchitis Virus